title: [What's new in gynecology in 2006?].
abstract: There were two good news in gynecologic oncology in 2006: intraperitoneal (IP) chemotherapy and the prophylactic vaccines for human papilloma virus (HPV). The ovarian cancer is usually limited to the peritoneal cavity and IP chemotherapy is associated with increased local concentrations. A benefit of this approach on survival was shown in three randomized trials and justifies the recommendation of this treatment for women with a Stage III ovarian cancer, after optimal surgery. Randomized trials have demonstrated the efficacy of two HPV vaccines to prevent a new infection and cytological abnormalities of the cervix. These vaccines will soon be available in Switzerland.
authors.affiliation: Service d'obstétrique, Département de gynecologie et d'obstétrique, Maternité, HUG, 1211 Genève.
authors.forename: P
authors.initials: P
authors.lastname: Petignat
authors.forename: A-T
authors.initials: AT
authors.lastname: Vlastos
authors.forename: H
authors.initials: H
authors.lastname: Bonnefoi
authors.forename: M
authors.initials: M
authors.lastname: Boulvain
mesh_terms: D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines
chemical_list: D053918:Papillomavirus Vaccines